Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 12 1997, 3232-3239, Vol 35, No. 12
C Carriere, PF Riska, O Zimhony, J Kriakov, S Bardarov, J Burns, J Chan and WR Jacobs Jr
TM4 is a lytic mycobacteriophage which infects mycobacteria of clinical
importance. A luciferase reporter phage, phAE40, has been constructed from
TM4 and was previously shown to be useful for the rapid detection and drug
susceptibility testing of Mycobacterium tuberculosis. However, the lytic
nature of the phage results in a loss of detectable light output and limits
the sensitivity of detection. We describe several strategies aimed at
improving the luciferase activity generated by TM4 luciferase phages,
including (i) varying the position of the luciferase gene in the phage
genome, (ii) isolating host-range mutants of the phage, and (iii)
introducing temperature-sensitive mutations in the phage such that it will
not replicate at the infecting temperature. Several new phages generated by
these methods show increased intensity of luciferase production compared to
the first-generation reporter phage phAE40, and one phage, phAE88, also
demonstrates an enhanced duration of luciferase activity. This has allowed
the detection of as few as 120 BCG cells and the determination of drug
susceptibilities of M. tuberculosis in as little as 1 day.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Conditionally replicating luciferase reporter phages: improved susceptibility for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis [In Process Citation]
Department of Microbiology and Immunology, Howard Hughes Medical Institute, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10461, USA.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|